UPDATED Apr 19, 2024
Discover French Pharmaceuticals & Biotech Growth Stocks that are on the CAC. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
SAN | €86.89 | 0.5% | -15.5% | €108.5b | €107.50 | PE20.1x | E13.8% | 4.3% | ||
VIRP | €376.00 | 3.0% | 26.0% | €3.1b | €361.56 | PE25.9x | E11.2% | 0.4% | ||
NANO | €5.25 | 0.2% | 50.2% | €247.3m | €11.30 | PS36.7x | E9.5% | n/a | ||
IPN | €108.40 | -0.9% | 2.2% | €9.0b | €124.63 | PE14.5x | E6.0% | 1.1% | ||
VETO | €96.10 | 0.3% | 10.1% | €1.1b | €108.64 | PE20.4x | E5.0% | 0.9% | ||
AB | €1.97 | -9.9% | -69.4% | €100.5m | €6.90 | PS129.3x | E1.4% | n/a | ||
BOI | €33.80 | -1.0% | -14.3% | €586.8m | €39.60 | PE12.3x | E-0.3% | 3.3% | ||
SIGHT | €0.41 | 2.6% | -43.8% | €32.0m | n/a | PS10.7x | E-10.0% | n/a | ||
MAAT | €8.72 | -8.0% | -8.2% | €101.2m | €15.50 | PS45.4x | E-15.4% | n/a | ||
TNG | €1.38 | -1.3% | -27.6% | €139.0m | €3.50 | PS17.6x | E-26.1% | n/a | ||
ALOPM | €1.57 | 1.3% | 46.7% | €26.2m | €2.48 | PS14.5x | E-28.7% | n/a | ||
GNRO | €1.43 | -3.1% | -27.6% | €42.3m | €4.00 | PE-3.2x | E-29.6% | n/a | ||
ABNX | €1.07 | -4.1% | -42.0% | €34.6m | €10.50 | PS7.5x | E-43.4% | n/a | ||
AELIS | €13.10 | 0.8% | -7.1% | €172.0m | €20.67 | PS13.9x | E-43.4% | n/a | ||
ALTHX | €1.05 | -7.9% | -26.6% | €8.1m | €4.00 | PS33x | n/a | n/a | ||
ALPRE | €4.10 | -8.9% | -29.3% | €15.2m | n/a | PS48.6x | n/a | n/a | ||
POXEL | €0.65 | 0.2% | -5.4% | €25.3m | n/a | PS16.4x | n/a | n/a | ||
ALVET | €0.78 | -6.0% | -72.2% | €2.5m | n/a | PS1.9x | n/a | n/a | ||
ALQGC | €0.12 | 2.4% | -14.7% | €4.1m | n/a | PS207.1x | n/a | n/a | ||
GV | €0.0018 | 0% | -91.3% | €692.9k | n/a | PE-0.07x | n/a | n/a | ||
ALPHA | €0.17 | -11.2% | -100.0% | €29.9k | n/a | PE-0.0009x | n/a | n/a | ||
ALNEV | €0.37 | -27.5% | -100.0% | €130.1k | n/a | PS2.4x | n/a | n/a | ||
PCA | €8.00 | 0% | 11.1% | €109.9m | n/a | PE12.5x | n/a | 0% | ||
ALNFL | €2.05 | 2.7% | -24.8% | €16.6m | €4.20 | n/a | n/a | n/a |